SonoTarg Ltd

SonoTarg Ltd is dedicated to revolutionizing cancer therapy through innovative, targeted approaches. Specializing in the hospitals and health care sector, SonoTarg focuses on enabling physicians to activate therapeutics specifically at the tumor site, minimizing the adverse effects of conventional chemotherapy. This pioneering technology, developed through collaborative research between the Universities of Ulster and Oxford, and in partnership with leading clinicians at Belfast Hospitals, positions SonoTarg at the forefront of medical advancements.

SonoTarg’s commitment to improving patient outcomes and advancing cancer treatment is evident in its specialized offerings, including microbubbles, cancer therapy, drug delivery, ultrasound therapy, and ultrasound applications. With its headquarters in Belfast and additional operations in Oxford, SonoTarg is strategically located to foster continued innovation and collaboration within the medical community. The company's approach aims to transform cancer care by enhancing precision and reducing patient burden.

SonoTarg Ltd continues to expand its reach and impact within the health care industry. Discover more about SonoTarg’s groundbreaking work and commitment to advancing cancer therapy on their website. We invite the manager of SonoTarg to create a customized and exclusive company showcase and product listing on our platform to further highlight their innovative solutions and drive commercial development.